Nxera Pharma Co Ltd (4565) Stock Price & News

4565:TYO

Nxera Pharma Co Ltd

¥1,222.00

+1.50%

(+18.00) 1D

Sep 14, 3:30:00 PM GMT+9 · JPY

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 4565...

Open

¥1,191

High

¥1,224

Low

¥1,177

Mkt. cap

113.17B

Avg. vol.

1.21M

Volume

929.90K

52-wk high

¥1,264

52-wk low

¥723

EPS

-¥86

Shares outstanding

76.30M

No. of employees

322

Open

¥1,191

High

¥1,224

Low

¥1,177

Mkt. cap

113.17B

Avg. vol.

1.21M

Volume

929.90K

52-wk high

¥1,264

52-wk low

¥723

EPS

-¥86

Shares outstanding

76.30M

No. of employees

322

Related stocks

Takeda Pharmaceutical Co Ltd

¥5,737.00

+1.25%

About Nxera Pharma Co Ltd

CEO-

Employees322

FoundedJun 22, 1990

Headquarters-

SectorPharmaceutical industry

Websitenxera.life

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	6.75B	7.77B	11.26B	7.65B
Cost of goods sold	2.67B	2.05B	1.12B	2.16B
Cost of revenue	2.67B	2.05B	1.12B	2.16B
Research and development expenses	3.73B	3.27B	3.03B	2.97B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.84B	363.00M	3.57B	3.38B
Operating expense	7.23B	8.08B	6.89B	6.85B
Total operating expenses	9.90B	10.13B	8.01B	9.02B
Operating income	-3.15B	-2.36B	3.24B	-1.36B
Other non operating income	-	-5.02B	-2.00M	2.00M
EBT including unusual items	-3.12B	-8.11B	3.04B	-1.64B
EBT excluding unusual items	-3.12B	-6.30B	3.04B	-1.64B
Income tax expense	-1.44B	-391.00M	1.25B	-1.44B
Effective tax rate	46.34%	4.82%	41.08%	87.71%
Other operating expenses	-338.00M	996.00M	295.00M	499.00M
Net income	-1.67B	-7.72B	1.79B	-202.00M
Net profit margin	-24.76%	-99.41%	15.93%	-2.64%
Earnings per share	-	-	-	-
Interest and investment income	239.00M	1.06B	144.00M	-
Interest expense	-204.00M	-	-287.00M	-488.00M
Net interest expenses	35.00M	1.06B	-143.00M	-488.00M
Depreciation and amortization charges	-	3.45B	-	-
EBITDA	-2.04B	-1.28B	4.35B	-268.00M
Gain or loss from assets sale	-	1.16B	-	1.21B

Finance

Ask anything